|Year : 2022 | Volume
| Issue : 4 | Page : 518-521
Clinical and epidemiological study of measles cases in central teaching hospital of pediatrics in Babylon Province
Ali Khalid Mohammed, Ahmed Raheem Nasir, Muhanned Muhdy Joda Alsweedy
Babylon Health Directorate, Babylon, Iraq
|Date of Submission||22-Mar-2022|
|Date of Acceptance||12-Apr-2022|
|Date of Web Publication||09-Jan-2023|
Ali Khalid Mohammed
Babylon Health Directorate, Babylon
Source of Support: None, Conflict of Interest: None
Background: It is an acute highly contagious disease occurs frequently in young children. It consists of three stages: An incubation stage of approximately 10–12 days. Prodromal stage with an enanthem (Koplik’s spots) on the buccal and pharyngeal mucosa, low grade fever, conjunctivitis, coryza, and sometimes-increasing cough. A final stage of a maculopopular rash erupting over the neck and face, body, arms, and legs associated with high fever. Objectives: The aim of this study was to determine the epidemiology, clinical features, complications, effectiveness of vaccine and treatment on cases of measles. Materials and Methods: Prospective case study of measles cases who are less than 13 years of age admitted to central teaching hospital of pediatrics during the period between 1/4/2015-1/10/2015 Diagnosis of measles was done by the classical history of the prodromal, fever, and cough, conjunctivitis, followed by the appearance of the classical rash after few days of the prodromal stage with the presence of the path gnomonic Kopliks spots in some patients. Chest X-rays (CXR) was done to all patients with suspicion of pneumonia. In addition to CBC and blood film. GSE was done to all patients with gastroenteritis, in addition to CBC. blood film and stool culture. Results: Two hundred seventy-seven patients were studied The male patients were (158, 57.03%) patients and the females were (119, 42.97%) patients, most of them (203, 73.28%) were not vaccinated (74, 26.72%) patients received the first dose of the vaccine at age of 9 months (21, 7.58%) patients received the first dose at 9 months with the second dose (MMR) at age of 15 months and only three patients (1.08%) received first, second, and third dose (MMR) at age of 4 years. The commonest clinical features were rash, fever, cough, conjunctivitis with coryza. Pneumonia was the commonest complication followed by gastroenteritis. There are only two cases of death: one due to severe pneumonia and the other due to septicemia and its complications. Conclusion: Measles is still a major health problem even in vaccinated children and the severity of illness is the same in both vaccinated and non-vaccinated children, with the peak age of incidence is during the second half of first year of life.
Keywords: Central teaching hospital, clinical, epidemiological study, measles
|How to cite this article:|
Mohammed AK, Nasir AR, Alsweedy MM. Clinical and epidemiological study of measles cases in central teaching hospital of pediatrics in Babylon Province. Med J Babylon 2022;19:518-21
|How to cite this URL:|
Mohammed AK, Nasir AR, Alsweedy MM. Clinical and epidemiological study of measles cases in central teaching hospital of pediatrics in Babylon Province. Med J Babylon [serial online] 2022 [cited 2023 Jan 30];19:518-21. Available from: https://www.medjbabylon.org/text.asp?2022/19/4/518/367351
| Introduction|| |
It is an acute highly contagious disease occurs frequently in young children. It consists of three stages: An incubation stage of approximately 10–12 days. Prodromal stage with an enanthem (Koplik’s spots) on the buccal and pharyngeal mucosa, low grade fever, conjunctivitis, coryza and sometimes-increasing cough. A final stage of a maculopopular rash erupting over the neck and face, body, arms and legs associated with high fever.,, Measles is endemic in most of the world. Epidemics tend to occur in spring especially in large cities. Communicability lasts for about 7 days from onset of prodrome and is maximal just before the rash appears. It’s an RNA virus of the family paramyxoviridae, genus morbillivirus. It is about 140 nm in diameter, with outer envelope consisting of lipid and protein. Measles virus is not a highly resistant organism, at room temperature it losses 60% of its infectivity in 3–5 days, Its half-life is 2 hours at 37 Centigrade and only half an hour at 56 Centigrade, but it preserves well in the cold environment., The age at which measles occurs varies according to the environment. In developing countries, it is common in infants between 6 months and 2 years. But in developed countries it is common in preschool-aged children and in teen ages and young adults who have been vaccinated.,, In temperate climates, measles is a winter disease and epidemics occur biannually. In tropical and subtropical countries, the disease is more prevalent during the late spring and summer months.,,, The incidence of measles in developed countries has decreased over the past 2 decades due to wide spread use of live attenuated measles vaccine. The essential lesion of measles is found in the skin, in the mucous membranes of the nasopharynx, bronchi, intestinal tract and the conjunctivae. Serous exudate and proliferation of mononuclear cells and few polymorphonuclear cells occur around the capillaries, in association with hyperplasia of lymphoid tissue, particularly in the appendix where multinucleated giant cells of up to 100 nm in diameter (warthin - Finkeldey reticuloendothelial giant cells) may be found. The skin lesion seen about the sebaceous glands and hair follicles. The Koplik spots consist of serous exudate and endothelial cells proliferation.,, The clinical feature of measles consist of prodromal stage: This stage begins about 10 days after infection and lasts until day 14, there is a fever, cough, coryza with conjunctivitis,the Koplik spots appear during the last 2 days of this phase. Exanthemata’s stage: The temperature increases suddenly as the rash appears and sometimes reaches 40–40.5 C. The rash appears as faint macules on the upper lateral parts of the neck, behind the ears and on the posterior parts of cheek., During the first 24 h the rash spreads rapidly over the whole face, neck, upper arms and upper part of chest.,, The treatment of measles consists of supportive measures, sedatives, antipyretics, bed rest and adequate fluid intake. Ribavirin is indicated for immune compromised patients with measles., Vitamin A supplementation is given for patients 6 months–2 years of age who are hospitalized for measles and its complications. The aim of this study is to determine the epidemiology of measles cases, the age group mostly affected, the sex ratio and the distribution of these cases whether it occur more in urban or rural areas in addition to the clinical features, the complications and the effects of vaccination and treatment on cases of measles.
| Materials and Methods|| |
Two hundred seventy-seven patients less than 13 years of age with a clinical diagnosis of measles admitted to central teaching hospital of pediatrics/ Babylon province/ Iraq. During the period from 1/4/2015-1/10/2015, 158 were males and 119 were females. The following information’s were obtained from parents including age, sex, residence, vaccination status, fever, cough, and coryza. Diagnosis of measles was done by the classical history of the prodromal, fever, cough, conjunctivitis followed by the appearance of the classical rash after few days of the prodromal with the presence of the pathognomonic Koplik spots in some patients. Chest X-rays (CXR) was done to all patients with suspicion of pneumonia. In addition to CBC and blood film. GSE was done to all patients with gastroenteritis, in addition to CBC. blood film and stool culture. Statistical analysis done SPSS 22 frequency and percentage used for categorical data, mean, median and SD for continuous data. Chi-square used for assessed association between variables, person correlation show the correlation between continuous data. P-value less or equal to 0.05 is consider significant.
The study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki. It was carried out with patients verbal and analytical approval before sample was taken. The study protocol and the subject information and consent form were reviewed and approved by a local ethics committee according to the document number 1234 (including the number and the date in 01/03/2015) to get this approval.
| Results|| |
The incidence of age of children included in study are shown in [Table 1]; more incidence occur in age>1 month–1 year (26.72%).
According to [Table 2], male (57%) and (61%) of children live on urban area. 100% of children have rash, 91% of them have fever.
|Table 2: Distribution of children according to sex, residence, and symptoms|
Click here to view
Most of patient 203 (73.28%) were not vaccinated, 74 (26.72%) received the first dose of vaccine at age of 9 months, 21 patients (7.58%) received the first dose at 9 months with second dose (MMR) at age of 15 months and only three patients (1.08%) received first, second, and third dose (MMR) at age of 4 years [Table 3].
Pneumonia was the commonest complication reported in 79 patients (28.51%) followed by gastroenteritis which is reported in 35 patients (12.63%). The list of complications, which were detected among the studied group in order of frequency, There are two cases of death: one because of severe pneumonia and its complications (female age 2 years and 5 months) and the other was due to septicemia (male age 19 months) [Table 4].
153 patients (55.23%) received antibiotics. 218 patients (78.70%) received vitamin A supplementation, of those only 15 patients (5.41%) had more than single dose of vitamin A. Intravenous fluid was given to some patients with gastroenteritis special those with repeated vomiting [Table 5].
| Discussion|| |
In this study, the peak age incidence of measles is during second half of first year of life because of the transplacental passage of maternal antibiotics which persist for the first 4–6 months of the life and disappear at variable rate. Marin et al. and Gastanaduy et al. found that the peak age incidence is during the second year of life, and Compel et al. and McLean et al. mentioned that the peak age incidence is in 5–10 years and preschool, teenage, respectively, while Jahan et al. found that the peak age incidence is in 6–11 months of age. There are two cases reported in this study, one aged 15 days’ male and the other was 23 days old female. Both of them were from rural areas with history of maternal and other sibling’s measles with no family member had received any measles vaccine. This is not reported in any other study as neonatal cases of measles. About the sex incidence there is no much difference between male and female ratio, with males 158 (57.03%) patients and females 119 (42.97%) patients, this incidence is about to be similar to what has been found by Marin et al. in which males were (46.25%) and females (53.75%), others like Herrera has found that males are (53.7%) and females are (46.3%). Although Jahan et al. found that males were (46.5%) and females (53.5%), Hyde et al. found that males were (52%) and females (48%). About the residence, the majority of patients came from urban areas (61.02%), whereas 38.98% came from rural areas, because the people in rural areas consult the primary health centers in the area and only complicated cases referred to the urban areas, these results are consistent with studies done by Benn et al. and Kiraly et al.. Hyde et al. found that (92%) of patients came from urban areas and (8%) only came from rural areas. The higher percentage of admitted cases to the hospital were during April (96) patients and the least number admitted during September (7) patients, this result about to be similar to what had been found by Lopez et al. who found that most of cases occur during Spring months. According to signs, symptoms and complications, the rash which is the commonest presenting feature occur in (100%) of patients. Hyde et al. found that it occurred in (96%) of cases. Fever appeared in (91.33%) of cases, Hyde et al. found that it occurred in (86.8%) of cases. The cough reported In (79.06%) of patients, whereas Gregory A. Poland et al. found that it occurred in (53.2%) of cases. Conjunctivitis occur in (77.61%) of cases, Gastroenteritis which is reported in (12.63%) of patients was reported to be only (8.7%) by Hyde et al., whereas Marin et al. found it (52.7%) and Kiraly et al. found it only (15%). Koplik’s spots reported in (4.33%) of patients, whereas others like Gregory A. Poland et al. found it occurred in (17.2%) of his cases. Pneumonia which was reported in (28.51%) of patients, was found to be only (7.5%) by Hyde et al. and (21.8%) by Kiraly et al. and (86.5%) by Marin et al. Otitis media reported in only 9 patients (3.24%) was found to be only (0.5%) by Hyde et al. Convulsion was not reported in any of patients but Marin et al. found it occur in (3.6%) and Kiraly et al. found it occur in (0.595%) of cases. About the vaccination status, most of cases (77.28%) were not vaccinated, whereas Jahan et al. found that (62.1%) were vaccinated and Hyde et al. found that (75%) of patients were vaccinated. There were (7.58%) of patients received the MMR at age of 15 months, Hyde et al. found that (42%) of patients received the MMR at age of 15 months. There are (2cases) dead in this study, 1 because of severe pneumonia and the other 1 due to septicemia, while in Hyde et al.’s study there are (3 cases) dead, 2 of them due to severe pneumonia and other 1 due to encephalitis. About the treatment, (55.23%) of patients received Antibiotics, while in Marin et al.’s study there are (26.3%) of cases received Antibiotics, and (46.2%) of cases received Antibiotics. (78.7%) of patients received Vitamin A supplementation while in Kiraly et al. it was (92.5%) of patients and in Hussein (67%) of patients received Vit. A supplementation.
| Conclusion|| |
Measles is still a major health problem even in vaccinated children and the severity of illness is the same in both vaccinated and non-vaccinated children, with the peak age of incidence is during the second half of first year of life.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Wilbert H Mason, Infectious Diseases, Nelson Text Book of Pediatrics. 18th ed. USA: W.B. Saunders; 2007. p. 1331-7.
DworKin PH Independent of Pediatrics. 5th ed. Winooski: PCC; 2003. p. 300-1.
Behrman RE, Kliegman R Nelson Essential of Pediatrics, Infectious Diseases, Measles. 5th ed. Philadelphia, PA: W. B. Saunders; 2006. p. 464-7.
Hussain HH, Ibraheem NT, Al-Rubaey NKF, Radhi MM, Hindi NKK, AL-Jubori RHK A review of airborne contaminated microorganisms associated with human diseases. Med J Babylon 2022;19:115-22.
Nsaif AK, Al-Joborae SFF Medical and social analysis of preschool children under the age of six years at secondary and tertiary care after home accidents in Hilla City. Med J Babylon 2022;19:169-75.
Malczyk AH, Kupke A, Prüfer S, Scheuplein VA, Hutzler S, Kreuz D, et al
. A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform. J Virol 2015;89:11654-67.
Gastañaduy PA, Banerjee E, DeBolt C, Bravo-Alcántara P, Samad SA, Pastor D, et al
. Public health responses during measles outbreaks in elimination settings: Strategies and challenges. Hum Vaccin Immunother 2018;14:2222-38.
Hampton T Outbreaks spur measles vaccine studies. JAMA 2011;306:2440-2.
Ventola CL Immunization in the United States: Recommendations, barriers, and measures to improve compliance: Part 1: Childhood vaccinations. P T 2016;41:426-36.
Callaghan T, Motta M, Sylvester S, Lunz Trujillo K, Blackburn CC Parent psychology and the decision to delay childhood vaccination. Soc Sci Med 2019;238:112407.
Imdad A, Mayo-Wilson E, Herzer K, Bhutta ZA Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev 2017;3:CD008524.
Michel Y, Saloum K, Tournier C, Quinet B, Lassel L, Pérignon A, et al
. Rapid molecular diagnosis of measles virus infection in an epidemic setting. J Med Virol 2013;85:723-30.
Moss WJ, Strebel P Biological feasibility of measles eradication. J Infect Dis 2011;204:S47-53.
Nørgård BM Birth outcome in women with ulcerative colitis and crohn’s disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Dan Med Bull 2011;58:B4360.
Christen U, Hintermann E Pathogens and autoimmune hepatitis. Clin Exp Immunol 2019;195:35-51.
Muñoz-Alía MÁ, Fernández-Muñoz R, Casasnovas JM, Porras-Mansilla R, Serrano-Pardo Á, Pagán I, et al
. Measles virus genetic evolution throughout an imported epidemic outbreak in a highly vaccinated population. Virus Res 2015;196:122-7.
Sabahelzain MM, Moukhyer M, van den Borne B, Bosma H Vaccine Hesitancy among Parents and Its Association with the Uptake of Measles Vaccine in Urban Settings in Khartoum State, Sudan. Vaccines 2022;10:205.
Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC). Use of combination measles, mumps, rubella, and varicella vaccine: Recommendations of the advisory committee on immunization practices (Acip). Mmwr Recomm Rep 2010;59:1-12.
McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: Summary recommendations of the advisory committee on immunization practices (ACIP). Mmwr Recomm Rep 2013;62:1-34.
Gastañaduy PA, Banerjee E, DeBolt C, Bravo-Alcántara P, Samad SA, Pastor D, et al
. Measles outbreak in Qassim, Saudi Arabia 2007: Epidemiology and evaluation of outbreak response. Journal of Public Health 2008;30:384-90.
Herrera OR, Thornton TA, Helms RA, Foster SL Mmr vaccine: When is the right time for the second dose? J Pediatr Pharmacol Ther 2015;20:144-8.
Hyde TB, Dayan GH, Langidrik JR, Nandy R, Edwards R, Briand K, et al
. Measles outbreak in the Republic of the Marshall Islands, 2003. Int J Epidemiol 2006;35:299-306.
Benn CS Combining vitamin A and vaccines: Convenience or conflict? Dan Med J 2012;59:B4378.
Kiraly N, Balde A, Lisse IM, Eriksen HB, Aaby P, Benn CS Vitamin A supplementation and risk of atopy: Long-term follow-up of a randomized trial of vitamin A supplementation at six and nine months of age. Bmc Pediatr 2013;13:190.
Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, et al
. One dose of varicella vaccine does not prevent school outbreaks: Is it time for a second dose? Pediatrics 2006;117:e1070-7.
Poland GA, Jacobson RM Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons. Arch Intern Med 1994;154:1815-20.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]